Ifetroban
Ifetroban (BMS-180291) is an orally active antagonist of thromboxane A2 (TXA2) or prostaglandin H2 (PGH2) receptor. Ifetroban shows antiplatelet activity, and inhibits tumor cell migration without affecting cell proliferation. Ifetroban can be used for myocardial ischemia, hypertension, stroke, thrombosis, cardiomyopathy research[1][2][3][4].
Product Specifications
CAS Number
143443-90-7
Product Name Alternative
BMS-180291
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cardiovascular Disease; Endocrinology; Cancer
Assay Protocol
https://www.medchemexpress.com/Ifetroban.html
Purity
99.65
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC(CCC(C=CC=C1)=C1C[C@@H]2[C@H](C3=NC(C(NCCCCC)=O)=CO3)[C@@H]4O[C@H]2CC4)=O
Molecular Formula
C25H32N2O5
Molecular Weight
440.53
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
TXA2/TP
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Boc-O-acetyl-L-serine dicyclohexylammonium salt ≥95% (HPLC)
Boc-O-acetyl-L-serine dicyclohexylammonium salt ≥95% (HPLC)
Boc-O-acetyl-L-serine dicyclohexylammonium salt ≥95% (HPLC)
Boc-O-acetyl-L-serine dicyclohexylammonium salt ≥95% (HPLC)
